Yu de laf lawd wan bak ɔ yu de fil bad? Dis kin bi Pseudobulbar Afɛkt (PBA)!

Yu dɔn ɛva si, ɔ ɛkspiriɛns, we pɔsin kin laf wantɛm wantɛm fɔ natin, ɔ we pɔsin kin kray we yu nɔ ebul fɔ kɔntrol? Sɔntɛnde, yu kin riak mɔ to smɔl tin pas di sɔri-at ɔ gladi at we yu kin fil. If yu dɔn gɛt dis ɛkspiriɛns, i impɔtant fɔ no bɔt di kɔndishɔn we wi go tɔk bɔt tide, Pseudobulbar Affect, ɔ PBA fɔ shɔt tɛm.

Yu no wetin na Pseudobulbar Affect (PBA)?

Fɔ tɔk am simpul wan, Pseudobulbar Affect (PBA) na wan nyurolɔjik kɔndishɔn we de mek yu laf ɔ kray we yu nɔ ebul fɔ kɔntrol, insay wan we we nɔ de mach yu tru tru filin. Imajin se yu gɛt sɔri-at, bɔt yu nɔ ebul fɔ stɔp fɔ laf. Ɔ, yu de na pati we gɛt gladi at, bɔt yu kin fil lɛk fɔ kray ɔltɛm. Dis na di men sayn fɔ PBA.

Dis sik kin kam bikɔs di bren dɔn pwɛl ɔr ɔda kayn nyurolɔjik sik kin kam. fכ egzampl, pכsin we gεt sik lεk ``Amyotrophic Lateral Sclerosis (ALS)`` kin gεt dis kכndyushכn.

Sɔntɛnde, pan ɔl we dis laf ɔ kray kin tan lɛk se i fayn da tɛm de, i kin at fɔ kɔntrol pas aw i kin bi. Dɔn bak, dɛn filin ya kin rili tranga ɛn kin las fɔ lɔng tɛm pas aw i kin bi . I tan lɛk se yu de on tap ɛn yu nɔ ebul fɔ stɔp am.

Dɛn kin kɔl PBA bak sɔm ɔda nem dɛn:

• Imɔshɔnal labiliti
• Pathological laf ɛn kray
• Dizayd fɔ sho aw pɔsin de fil we i nɔ want
• Fɔ laf ɔ kray we pɔsin kin fos fɔ du
• Imɔshɔnal inkɔntinɛns (inability fɔ kɔntrol di filin) ​​.

PBA kin gɛt big impak pan yu layf, yu famili, ɛn di wan dɛn we de kia fɔ yu. I kin mek pɔsin fil shem, wɔri , ɛn ivin de fa frɔm ɔda pipul dɛn.

Aw kɔmɔn tin fɔ PBA?

Risach pipul dɛm se na bitwin 2 ɛn 7 milyɔn pipul dɛm na Amɛrika nɔmɔ de sɔfa wit PBA. di rizin fכ dis big rεnj in nכmba na biכs PBA difrεn pan di siriכs εn dεn nכ de no am fayn. I pɔsibul se pipul dɛm wae gɛt dis sik na Sri Lanka nɔr de gɛt tritmɛnt bak bikɔs dɛn nɔr no natin.

Udat dɛn PBA kin afɛkt mɔ?

Dis sik we dɛn kɔl Pseudobulbar Affect (PBA), kin afɛkt ɛnibɔdi we gɛt ɛni ej, ivin pikin ɛn big pipul, wit sɔm kayn nyurolɔjik sik na di bren.

As stɔdi dɛn dɔn sho:

• Na lɛk 50% pan di pipul dɛm wae gɛt Amyotrophic Lateral Sclerosis (ALS) kin gɛt PBA.
• Na lɛk 48% pan di pipul dɛm wae gɛt traumatik bren injury (TBI) ɔr siriɔs bren injury.
• Dis sik kin afɛkt lɛk 46% pan pipul dɛm wae gɛt Multiple Sclerosis (MS).

Pseudobulbar Affect na mental sik?

Sɔm pipul kin tink se PBA na mental sik. Na bikɔs dɛn tin ya lɛk fɔ laf ɛn kray gɛt sɔntin fɔ du wit di we aw wi de fil. כltu, biכs PBA de kכz fכ damej pan di nyural sεkyut dεm na di bren , dεn kכl am as `nyurosaykayatrik sεndrכm`, dat na, wan kכlekshכn fכ nyurosaykayatrik simptom dεm. Fɔ tɔk am simpul wan, PBA na wan dizayd fɔ sho aw pɔsin de fil we kin apin wit wan sik na di bren.

Wetin na di sayn dɛm fɔ PBA?

fכ כndastand PBA, i imכtant fכ no di difrεns bitwin 'mud' εn 'affect'. Mud na di filin we yu gɛt insay yusɛf. Dat min se, tin dɛn we na yu nɔmɔ go ebul fɔ fil, lɛk fɔ fil bad, fɔ vɛks, ɔ fɔ gɛt gladi at. Affect na di we aw yu de sho aw yu de fil na do, lɛk fɔ smayl ɔ kray, we ɔda pipul dɛn kin si.

So, di men sayn fɔ Pseudobulbar Affect (PBA) na fɔ sho aw yu de fil (affect) we nɔr de mach yu mud ɔr di intensiti fɔ yu filin. Di sayn dɛm wae kin kam pan pɔrsin na wae yu de kray ɛn laf.

Dis laf ɛn/ɔ kray kin tan lɛk dis:

• I nɔ bin de ɛkspɛkt, i kin apin wantɛm wantɛm, ɛn i nɔ kin ebul fɔ kɔntrol insɛf.
• Tumɔs fɔ di ivent. (e.g. laf fɔ awa pan smɔl jok)
• I kin apin fɔ no rizin.

Sɔntɛnde, pɔsin kin vɛks ɔ fil bad we pɔsin nɔ ebul fɔ kɔntrol.

Bikɔs PBA kin gɛt fɔ du wit wan ɔndalayn nyurolɔjik kɔndishɔn lɛk bren injuri ɔ amyotrophic lateral sclerosis (ALS), pipul dɛn we gɛt PBA kin gɛt ɔda simptom dɛn bak we gɛt fɔ du wit di ɔndalayn kɔndishɔn.

Wetin na di tin dɛn we kin mek pɔsin gɛt PBA?

Risach pipul dɛm stil nɔr no di rayt kɔz fɔ Pseudobulbar Affect. Dɛn tink se na bikɔs ɔf disrɔpshɔn na di nyurolɔjik path dɛm na wi bren we de kɔntrol aw wi de sho aw wi de fil.

difrεn nyurolכjik kכndishכn dεm de we de asai wit PBA we kin mek dεn disturbans ya:

• Traumatik bren injuri
• Amyotrophic lateral sclerosis (ALS), we dɛn kin kɔl bak Lu Gehrig in sik.
• Mɔltipɛl sklɛrosis (MS) .
• Alzaima sik ɛn ɔda kayn dis maynia sik
• Strok
• Dis sik we dɛn kɔl Parkinson
• Tumɔs dɛn na di bren
• Epilepsy we pɔsin kin gɛt
• Wilson in sik we dɛn kɔl Wilson

Us pat dɛn na di bren we PBA kin afɛkt?

dεn tink se PBA kin afekt difrεn εria dεm na di bren along di sεribro-ponto-sεribεl path.

pat pan dis rod na wi sכm sכm bren (Cerebellum).Dis kin bi bay we wi de wach aw wi de fil ɛn mek shɔ se dɛn fit fɔ di soshal sityueshɔn. if di nyural path dεm we de kכmכt frכm sכm εria dεm na di bren to di sεribεl dεm nכ de wok, dεn kin lכs di kכntrכl pan di εksprεshכn fכ di imכshכn dεm.

apat frכm dat, dεn nyurotransmit dεm ya kin involv insay PBA:

• Serotonin we gɛt di sik
• Norepinephrin `(Norepinephrine)`
• Dopamin we dɛn kɔl Dopamin
• Glutamɛt we dɛn kɔl
• Asetilkolin `(Asetilkolin)`

Aw dɛn kin no se pɔsin gɛt PBA?

Pseudobulbar affect (PBA) kin bi wan triki kכndyushכn fכ no . Ivin dɔktɔ kin mistek sɔmtɛm fɔ bi mɛntɛl sik – mɔr lɛk pwɛl hat ɔr bipolar disorder.

Naw, no patikyula tɛst nɔ de fɔ no if pɔsin gɛt PBA. Dɔktɔ dɛn kin no di sik bay we dɛn de fala yu:

• Sayn dɛn
• Mɛdikal istri, mɔ bɔt nyurolɔjik sik dɛn
• Mental hεlth histri
• Infɔmeshɔn frɔm di fyzikal ɛgzamin

Dɛn kin tek tɛm stɔdi ɔl dis ɛn dɛn kin kam fɔ no sɔntin.

Wetin mek dɛn kin kɔnfyus PBA wit pwɛl hat?

Pseudobulbar affect (PBA) na wan sik wae dɛn kin kɔnfyus wit mɛntɛl sik, mɔr lɛk pwɛl hat.

Dis na wetin kin apin we yu kin kray ɔltɛm, we na wan big sayn fɔ PBA. Pipul wae gɛt PBA kin gɛt pwɛl hat bak fɔ ɔda rizin, ɛn bak bikɔs ɔf de PBA kɔndishɔn insɛf. Bɔt, we yu kɔmpia am wit pwɛl hat, kray episɔd dɛn na PBA:

• I kin bigin wantɛm wantɛm, lɛk se i de bɔn.
• I kin jɔs las fɔ shɔt tɛm.
• Bɔrku tɛm, nɔr kin gɛt fɔ du wit pwɛl hat wae de mɛk pɔrsin fil fayn fɔ lɔng tɛm.

Pan ɔl we pipul dɛn we gɛt pwɛl hat kin fil bad ɔltɛm, dɛn nɔ kin kray ɔltɛm. Ivin if dem du am, i de las pas fo PBA. Dɔn bak, ɔda sayn dɛm fɔ pwɛl hat, lɛk wae pɔrsin nɔr kin slip ɛn nɔr kin want fɔ it, nɔr kin si pan PBA.

Wetin na di tritmɛnt dɛm fɔ PBA?

No mɛrɛsin nɔ de fɔ Pseudobulbar Affect (PBA). Bɔt, mɛrɛsin dɛn de we kin ɛp fɔ kɔntrol am. Di men gol fɔ tritmɛnt na fɔ ridyus di kayn we aw dɛn kin laf ɛn kray we dɛn nɔ kin kɔntrol.

Di kayn mɛrɛsin dɛn we dɔktɔ dɛn kin gi fɔ PBA na:

• Dextromethorphan/quinidine sulfate (Nuedexta®): Dis na di fɔs mɛrɛsin we di FDA (US Food and Drug Administration) dɔn gri fɔ fɔ trit PBA. I gɛt wan mɛrɛsin fɔ kɔf (dextromethorphan) ɛn wan rili smɔl doz fɔ wan mɛrɛsin we dɛn bin de yuz fɔ trit at ritm dizayd (quinidine sulfate).
• Di mɛrɛsin dɛn we de mek pɔsin nɔ fil bad:Antidipreshan dɛm lɛk `(Tricyclic antidepressants)`, `(Sɛlektiv Serotonin Riuptek Inhibitors - SSRIs)`, ɛn `(Norepinephrine/Serotonin Riupteke Inhibitors - SNRIs)` kin ɛp fɔ kɔntrol di PBA simptom dɛm. Bɔt dɛn kin gi dɛn tin ya na smɔl dos pas di wan dɛn we dɛn kin gi fɔ pwɛl hat.

Jɔs lɛk ɔl di mɛrɛsin dɛn, sayd ɛfɛkt kin apin. Yu fɔ wok wit dɔktɔ fɔ pik di tritmɛnt plan we go fayn fɔ yu.

Yu tink se dɛn kin ebul fɔ stɔp PBA?

Bikɔs Pseudobulbar Affect na bikɔs di bren dɔn pwɛl ɛn di nyurolɔjik kɔndishɔn, natin nɔ de we dɛn kin du fɔ mek i nɔ apin.

Wetin na di prɔgnosis fɔ PBA?

Di luk fɔ PBA dɛn kin difrɛn frɔm wan pɔsin to ɔda pɔsin.

If dɛn nɔ no ɛn trit di sik, pipul dɛn we gɛt PBA kin gɛt mɔ risk fɔ:

• Pwɛl at
• Wɔri
• Di soshal kɔnekshɔn dɛn we dɔn go dɔŋ
• Di kwaliti fɔ layf we dɔn go dɔŋ

Mɛrɛsin kin ɛp fɔ kɔntrol di sayn dɛm. I kin tranga fɔ no ɛn trit am. Bɔt, i impɔtant fɔ mek yu tɔk fɔ yusɛf ɛn tray. Di dɔktɔ dɛm wae sabi dis sik pas ɔl na di nyurosaykolog dɛm, nyurolɔjis dɛm, ɛn saykayatrist dɛm.

Aw lɔŋ Pseudobulbar Afɛkt kin las?

Pseudobulbar afekt kin bi wan krεse sik, as di כndalayn mεdikal kכndyushכn dεm we de mek am (e.g., mכltipכl sklεrosis, Alzaima sik) kin te fכ lכng tεm.

Wetin yu kin du fɔ liv fayn fayn wan wit PBA? (Strateji dɛn fɔ bia wit di prɔblɛm)

Na sɔm advays dɛn fɔ ɛp yu fɔ bia wit PBA ɛn kɔntrol di we aw yu de laf/krai wantɛm wantɛm:

• We di laf/krai kam, tek dip briz te i stɔp.
• Tink bɔt ɔda tin da tɛm de, pe atɛnshɔn pan am.
• Rilaks yu sholda ɛn yu fes mɔsul dɛn ɛn ridyus di tɛnsiɔn.
• If i pɔsibul, chenj yu pozishɔn.
• Tɛl ɔda pipul dɛn bɔt yu situeshɔn so dat dɛn go no wetin fɔ ɛkspɛkt ɛn nɔr go misɔndastand yu.
• If PBA de afɛkt yu maynd wɛlbɔdi, go to pɔsin we de gi advays bɔt yu maynd .

Ustɛm a fɔ go to dɔktɔ?

If yu gɛt PBA, yu tritmɛnt nɔ de wok fayn, ɔ yu de gɛt sayd ɛfɛkt we nɔ fayn, tɔk to yu dɔktɔ bɔt nyu tritmɛnt.

Fɔ laf ɛn kray we pɔsin nɔ ebul fɔ kɔntrol, i kin tranga, i kin mek i shem, ɛn i nɔ kin izi fɔ ɔda pipul dɛn fɔ ɔndastand. Bɔt mɛmba se, Pseudobulbar Affect (PBA) na mɛrɛsin, ɛn dɛn kin ebul fɔ kɔntrol am wit mɛrɛsin. If yu gɛt sayn fɔ PBA, tɔk to dɔktɔ. Dɛn de ya fɔ ɛp yu.

Di impɔtant tin dɛn we yu nid fɔ mɛmba frɔm wetin wi dɔn tɔk bɔt (Take-Home Message)

Okay, so na di impɔtant tin dɛn we yu nid fɔ mɛmba bɔt Pseudobulbar Affect (PBA) we wi tɔk bɔt tide:

• PBA na nyurolɔjik kɔndishɔn we de mek yu laf ɔ kray we yu nɔ ebul fɔ kɔntrol, pan we we nɔ de mach yu filin.
• Dis kin gɛt fɔ du wit ɔda nyurolɔjik sik (e.g. ALS, MS, Stroke, TBI).
• PBA nɔto mɛntɛl sik insɛf, bɔt dɛn kin kɔnfyus am wit tin dɛm lɛk pwɛl hat.
• Pan ɔl we no kɔmplit mɛrɛsin nɔ de fɔ dis, mɛrɛsin dɛn de fɔ kɔntrol di sik dɛn.
• If yu gɛt dɛn kayn sik ya, i rili impɔtant fɔ go to dɔktɔ we nɔ go shem ɔ fred.
• We yu tɛl di wan dɛn we yu lɛk bɔt dis tin we go apin to yu, dat go mek tin izi fɔ yu ɛn dɛn.

A op se dis infɔmeshɔn go ɛp yu. If yu gɛt ɛni ɔda kwɛstyɔn bɔt dis, duya nɔ shem fɔ tɔk to dɔktɔ.

` Pseudobulbar Afɛkt, PBA, Nyuropati, Laf we nɔ kin kɔntrol, kray we nɔ kin kɔntrol, Imɔshɔnal Labiliti, Bren Disɔda